1507 related articles for article (PubMed ID: 16242629)
21. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
22. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
23. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ
J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063
[TBL] [Abstract][Full Text] [Related]
24. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
[TBL] [Abstract][Full Text] [Related]
25. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
26. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress.
Surkin PN; Gallino SL; Luce V; Correa F; Fernandez-Solari J; De Laurentiis A
Psychoneuroendocrinology; 2018 Jan; 87():131-140. PubMed ID: 29065362
[TBL] [Abstract][Full Text] [Related]
28. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
[TBL] [Abstract][Full Text] [Related]
29. A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.
Solbrig MV; Adrian R; Baratta J; Piomelli D; Giuffrida A
Exp Neurol; 2005 Aug; 194(2):355-62. PubMed ID: 16022863
[TBL] [Abstract][Full Text] [Related]
30. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
[TBL] [Abstract][Full Text] [Related]
31. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
[TBL] [Abstract][Full Text] [Related]
32. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.
Tsumura M; Sobhan U; Muramatsu T; Sato M; Ichikawa H; Sahara Y; Tazaki M; Shibukawa Y
Cell Calcium; 2012 Aug; 52(2):124-36. PubMed ID: 22656960
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
Haranishi Y; Hara K; Terada T
Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
[TBL] [Abstract][Full Text] [Related]
34. The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor.
Williams MA; Smith SA; O'Brien DE; Mitchell JH; Garry MG
J Physiol; 2008 Feb; 586(3):835-45. PubMed ID: 18063665
[TBL] [Abstract][Full Text] [Related]
35. Effect of capacitation on the endocannabinoid system of mouse sperm.
Catanzaro G; Battista N; Rossi G; Di Tommaso M; Pucci M; Pirazzi V; Cecconi S; Maccarrone M
Mol Cell Endocrinol; 2011 Aug; 343(1-2):88-92. PubMed ID: 21723369
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis.
Rossi S; Furlan R; De Chiara V; Muzio L; Musella A; Motta C; Studer V; Cavasinni F; Bernardi G; Martino G; Cravatt BF; Lutz B; Maccarrone M; Centonze D
Brain Behav Immun; 2011 Aug; 25(6):1242-8. PubMed ID: 21473912
[TBL] [Abstract][Full Text] [Related]
37. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.
Steiner AA; Molchanova AY; Dogan MD; Patel S; Pétervári E; Balaskó M; Wanner SP; Eales J; Oliveira DL; Gavva NR; Almeida MC; Székely M; Romanovsky AA
J Physiol; 2011 May; 589(Pt 9):2415-31. PubMed ID: 21486787
[TBL] [Abstract][Full Text] [Related]
38. Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.
Morgese MG; Cassano T; Cuomo V; Giuffrida A
Exp Neurol; 2007 Nov; 208(1):110-9. PubMed ID: 17900568
[TBL] [Abstract][Full Text] [Related]
39. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
[TBL] [Abstract][Full Text] [Related]
40. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
